Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-10

Clinical Trial Update: The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled trial evaluating incobotulinum toxin A injections for tinnitus has completed, with reported efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Incobotulinum Toxin A (incobotulinum toxin A)

Snippet

Sponsor: University of Minnesota | Conditions: Tinnitus | Phase 2 | Status: COMPLETED